Company Profile for DA32 Life Science Tech Acquisition Corp. Share
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
Company Data
NameDA32 Life Science Tech Acquisition Corp.
CompanyDA32 Life Science Tech Acquisition Corp.
SymbolDALS
Primary Exchange
NASDAQ
ISINUS23312M1062
Asset ClassShare
SectorFinancial Services
IndustryShell Companies
CEOSteven Kafka
Market Capitalization264 Mio
CountryUnited States of America
CurrencyUSD
Employees-
Address345 Park Avenue South, 10010 New York City
IPO Date2021-07-28
Ticker Symbols
Name
Symbol
NASDAQ
DALS
More Shares
Investors who hold DA32 Life Science Tech Acquisition Corp. also have the following shares in their portfolio: